The role of podoplanin inhibitors in controlling oral cancer progression

Objective: In this article, we review the current studies on the role of podoplanin in oral cancer and the potential application of podoplanin inhibitors as a therapeutic agent for oral cancer. Design: The narrative review approach was conducted, providing a comprehensive perspective of related li...

Full description

Saved in:
Bibliographic Details
Main Authors: Engku Ngah Sayuddin, Engku Nasiha, Bakhtiar, Muhammad Taher, Arzmi, Mohd Hafiz, Burhanudin, Nor Aszlitah, Rostam, Muhamad Ashraf
Format: Article
Language:English
English
Published: Elsevier Ltd. All 2023
Subjects:
Online Access:http://irep.iium.edu.my/108063/7/108063_The%20role%20of%20podoplanin%20inhibitors.pdf
http://irep.iium.edu.my/108063/13/108063_The%20role%20of%20podoplanin%20inhibitors_Scopus.pdf
http://irep.iium.edu.my/108063/
https://www.sciencedirect.com/science/article/pii/S0003996923002297?dgcid=author
https://doi.org/10.1016/j.archoralbio.2023.105841
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.iium.irep.108063
record_format dspace
spelling my.iium.irep.1080632024-01-08T05:29:10Z http://irep.iium.edu.my/108063/ The role of podoplanin inhibitors in controlling oral cancer progression Engku Ngah Sayuddin, Engku Nasiha Bakhtiar, Muhammad Taher Arzmi, Mohd Hafiz Burhanudin, Nor Aszlitah Rostam, Muhamad Ashraf RK Dentistry RM Therapeutics. Pharmacology Objective: In this article, we review the current studies on the role of podoplanin in oral cancer and the potential application of podoplanin inhibitors as a therapeutic agent for oral cancer. Design: The narrative review approach was conducted, providing a comprehensive perspective of related literature. Publications addressing podoplanin and its inhibitors in the context of oral cancer were retrieved from PubMed and Scopus databases. Results: Podoplanin has emerged as a biomarker and therapeutic agent for oral cancer. Numerous studies have reported high podoplanin expression in oral cancer and pre-cancerous lesions compared to normal cells. A specific inhibitor targeting podoplanin may have the potential to prevent oral carcinogenesis via interfering with the pathway of cancerous cells involved in cell proliferation and metastasis. Antibodies, chimeric antigen receptor (CAR)-T cells, cancer-specific mAb (CasMab), synthetic molecules, and lectins are among the materials used as anticancer agents targeting podoplanin. Plant-derived lectins appear to demonstrate a unique advantage against alternative candidates. Conclusions: The use of podoplanin inhibitors in place of existing therapeutic approaches could be a promising and novel approach to the prevention and treatment of oral cancer. Nevertheless, further research is required to investigate the practical application of such inhibitors. Elsevier Ltd. All 2023-11-01 Article PeerReviewed application/pdf en http://irep.iium.edu.my/108063/7/108063_The%20role%20of%20podoplanin%20inhibitors.pdf application/pdf en http://irep.iium.edu.my/108063/13/108063_The%20role%20of%20podoplanin%20inhibitors_Scopus.pdf Engku Ngah Sayuddin, Engku Nasiha and Bakhtiar, Muhammad Taher and Arzmi, Mohd Hafiz and Burhanudin, Nor Aszlitah and Rostam, Muhamad Ashraf (2023) The role of podoplanin inhibitors in controlling oral cancer progression. Archives of Oral Biology, 157. pp. 1-7. ISSN 0003-9969 E-ISSN 1879-1506 https://www.sciencedirect.com/science/article/pii/S0003996923002297?dgcid=author https://doi.org/10.1016/j.archoralbio.2023.105841
institution Universiti Islam Antarabangsa Malaysia
building IIUM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider International Islamic University Malaysia
content_source IIUM Repository (IREP)
url_provider http://irep.iium.edu.my/
language English
English
topic RK Dentistry
RM Therapeutics. Pharmacology
spellingShingle RK Dentistry
RM Therapeutics. Pharmacology
Engku Ngah Sayuddin, Engku Nasiha
Bakhtiar, Muhammad Taher
Arzmi, Mohd Hafiz
Burhanudin, Nor Aszlitah
Rostam, Muhamad Ashraf
The role of podoplanin inhibitors in controlling oral cancer progression
description Objective: In this article, we review the current studies on the role of podoplanin in oral cancer and the potential application of podoplanin inhibitors as a therapeutic agent for oral cancer. Design: The narrative review approach was conducted, providing a comprehensive perspective of related literature. Publications addressing podoplanin and its inhibitors in the context of oral cancer were retrieved from PubMed and Scopus databases. Results: Podoplanin has emerged as a biomarker and therapeutic agent for oral cancer. Numerous studies have reported high podoplanin expression in oral cancer and pre-cancerous lesions compared to normal cells. A specific inhibitor targeting podoplanin may have the potential to prevent oral carcinogenesis via interfering with the pathway of cancerous cells involved in cell proliferation and metastasis. Antibodies, chimeric antigen receptor (CAR)-T cells, cancer-specific mAb (CasMab), synthetic molecules, and lectins are among the materials used as anticancer agents targeting podoplanin. Plant-derived lectins appear to demonstrate a unique advantage against alternative candidates. Conclusions: The use of podoplanin inhibitors in place of existing therapeutic approaches could be a promising and novel approach to the prevention and treatment of oral cancer. Nevertheless, further research is required to investigate the practical application of such inhibitors.
format Article
author Engku Ngah Sayuddin, Engku Nasiha
Bakhtiar, Muhammad Taher
Arzmi, Mohd Hafiz
Burhanudin, Nor Aszlitah
Rostam, Muhamad Ashraf
author_facet Engku Ngah Sayuddin, Engku Nasiha
Bakhtiar, Muhammad Taher
Arzmi, Mohd Hafiz
Burhanudin, Nor Aszlitah
Rostam, Muhamad Ashraf
author_sort Engku Ngah Sayuddin, Engku Nasiha
title The role of podoplanin inhibitors in controlling oral cancer progression
title_short The role of podoplanin inhibitors in controlling oral cancer progression
title_full The role of podoplanin inhibitors in controlling oral cancer progression
title_fullStr The role of podoplanin inhibitors in controlling oral cancer progression
title_full_unstemmed The role of podoplanin inhibitors in controlling oral cancer progression
title_sort role of podoplanin inhibitors in controlling oral cancer progression
publisher Elsevier Ltd. All
publishDate 2023
url http://irep.iium.edu.my/108063/7/108063_The%20role%20of%20podoplanin%20inhibitors.pdf
http://irep.iium.edu.my/108063/13/108063_The%20role%20of%20podoplanin%20inhibitors_Scopus.pdf
http://irep.iium.edu.my/108063/
https://www.sciencedirect.com/science/article/pii/S0003996923002297?dgcid=author
https://doi.org/10.1016/j.archoralbio.2023.105841
_version_ 1787520328195375104
score 13.209306